Renovaro Biosciences Inc Cash Flow-to-Debt Ratio
Renovaro Biosciences Inc cash flow-to-debt ratio. Renovaro Biosciences Inc (RENB) has a Cash Flow-to-Debt Ratio of -0.06x as of June 2025, meaning its operating cash flow of $-1.81 Million could theoretically repay 0% of its total liabilities ($29.58 Million) in one year. Check cash flow quality index of Renovaro Biosciences Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Renovaro Biosciences Inc (2012–2025)
Cash flow-to-debt ratio of Renovaro Biosciences Inc from 2012 to 2025. Historical debt coverage capacity for Renovaro Biosciences Inc across 14 annual periods. Also explore Renovaro Biosciences Inc (RENB) equity growth momentum to track the company's year-over-year net asset growth rate.
Renovaro Biosciences Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
Renovaro Biosciences Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Renovaro Biosciences Inc. For the full cash flow conversion analysis, see RENB operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.35x | $-10.97 Million | $31.15 Million | ▲ +0.0% |
| 2024 | -0.35x | $-10.97 Million | $31.15 Million | ▲ +64.7% |
| 2023 | -1.00x | $-11.77 Million | $11.80 Million | ▲ +23.8% |
| 2022 | -1.31x | $-15.73 Million | $12.01 Million | ▲ +5.1% |
| 2021 | -1.38x | $-20.61 Million | $14.94 Million | ▼ -56.0% |
| 2020 | -0.88x | $-10.46 Million | $11.83 Million | ▲ +29.6% |
| 2019 | -1.26x | $-8.51 Million | $6.78 Million | ▼ -587.6% |
| 2018 | -0.18x | $-4.34 Million | $23.76 Million | ▲ +53.7% |
| 2017 | -0.39x | $-1.18 Million | $2.99 Million | ▲ +59.7% |
| 2016 | -0.98x | $-1.47 Million | $1.51 Million | ▲ +15.7% |
| 2015 | -1.16x | $-2.03 Million | $1.76 Million | ▼ -14.1% |
| 2014 | -1.01x | $-2.13 Million | $2.10 Million | ▼ -140.1% |
| 2013 | -0.42x | $-30.09K | $71.23K | ▲ +53.9% |
| 2012 | -0.92x | $-24.95K | $27.23K | — |